Osteome Synthetica LLC

Ship of Theseus LLC is a Philadelphia-based therapeutics company specializing in the development of degradation-resistant biologics derived from the HOX family of transcription factors. By creating proprietary modifications to HOX proteins, the company aims to extend their effectiveness as pharmaceuticals, thus addressing challenges associated with frequent repeat dosing. The company has made significant advancements in its research, including winning prestigious awards for its innovations in wound healing and receiving grants to support its preclinical developments in stem cell expansion. Through strategic partnerships and a commitment to longevity science, Ship of Theseus is positioned at the forefront of therapeutic research, particularly in the areas of chronic wounds and recovery following chemotherapy. Generated from the website

Longevity Biotech, Inc., based in Philadelphia, PA, is dedicated to advancing innovative solutions in the field of neurodegenerative diseases through its precision neuroscience approach. The company utilizes its proprietary Hybridtide Platform to develop therapies aimed at rebalancing the immune system and addressing conditions such as Parkinson's disease. With a strong leadership team and a network of scientific advisors, Longevity Biotech is committed to pioneering research and clinical trials that push the boundaries of current treatment methodologies. Their focus on precision approaches positions them at the forefront of biotechnology aimed at improving patient outcomes in neurodegenerative disorders. Generated from the website

Integral Molecular, located in Philadelphia, PA, is a leading biotechnology company specializing in membrane proteome arrays, virology reagents and services, lipoparticles, virus-like particles (VLPs), antibody discovery, epitope mapping, and protein engineering. The company offers cutting-edge technologies for research and development, with a focus on advancing scientific discoveries in the fields of molecular biology, virology, and antibody therapeutics. Generated from the website